Zobrazeno 1 - 10 of 17 pro vyhledávání: '"Vesa V Kataja"'
1
Akademický článek
Electronic patient-reported outcomes and machine learning in predicting immune-related adverse events of immune checkpoint inhibitor therapies
Autor: Sanna Iivanainen, Jussi Ekstrom, Henri Virtanen, Vesa V. Kataja, Jussi P. Koivunen
Publikováno v: BMC Medical Informatics and Decision Making, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background Immune-checkpoint inhibitors (ICIs) have introduced novel immune-related adverse events (irAEs), arising from various organ systems without strong timely dependency on therapy dosing. Early detection of irAEs could result in impro
Externí odkaz: https://doaj.org/article/bbc616ea2edc46f6bd8e030ee67dcf98
Zobrazit plný text záznamu
2
Akademický článek
Predicting Objective Response Rate (ORR) in Immune Checkpoint Inhibitor (ICI) Therapies with Machine Learning (ML) by Combining Clinical and Patient-Reported Data
Autor: Sanna Iivanainen, Jussi Ekström, Henri Virtanen, Vesa V. Kataja, Jussi P. Koivunen
Publikováno v: Applied Sciences, Vol 12, Iss 3, p 1563 (2022)
ICIs are a standard of care in several malignancies; however, according to overall response rate (ORR), only a subset of eligible patients benefits from ICIs. Thus, an ability to predict ORR could enable more rational use. In this study a ML-based OR
Externí odkaz: https://doaj.org/article/b9e2d29ab44e452a97a21fc93801a593
Zobrazit plný text záznamu
3
Electronic patient-reported outcomes and machine learning in predicting immune-related adverse events of immune checkpoint inhibitor therapies
Autor: Henri Virtanen, Sanna Iivanainen, Vesa V. Kataja, Jussi Ekström, Jussi Koivunen
Publikováno v: BMC Medical Informatics and Decision Making
BMC Medical Informatics and Decision Making, Vol 21, Iss 1, Pp 1-8 (2021)
Background Immune-checkpoint inhibitors (ICIs) have introduced novel immune-related adverse events (irAEs), arising from various organ systems without strong timely dependency on therapy dosing. Early detection of irAEs could result in improved toxic
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a82d64a9617f6bb8a95276e5df4d0c65
http://europepmc.org/articles/PMC8243435
Zobrazit plný text záznamu
4
Digital patient-reported outcomes and serological response to SARS-COV-2 vaccines in patients with cancer
Autor: Jose L. Sandoval, Sebastien Bugeia, Santeri Mentu, Garance Gutknecht, Jussi Ekström, Anna Battagin, Alex Friedlaender, Mari Metso-Lintula, Vesa V Kataja, Pierre-Yves Dietrich, Nicolas Mach, Alfredo Addeo
Publikováno v: Journal of Clinical Oncology. 40:e13606-e13606
e13606 Background: SARS-CoV-2 vaccines have changed the course of the current global pandemic. Cancer patients were identified as highrisk of adverse infection outcomes. We have previously characterised the serological response to SARS-CoV-2 vaccines
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b05fa29f9d577d7bcd2bd783e98b83fc
https://doi.org/10.1200/jco.2022.40.16_suppl.e13606
Zobrazit plný text záznamu
5
Long-term safety of darolutamide in patients with metastatic castration-resistant prostate cancer
Autor: Egils Vjaters, Karim Fizazi, Nicholas D. James, Teuvo Tammela, Nobuaki Matsubara, Frank Priou, Thierry Lesimple, Petri Bono, Vesa V Kataja, Jorge A. Garcia, Andrew Protheroe, John Aspegren, Heikki Joensuu, Iris Kuss, Silke Thiele, Sabine Fiala-Buskies, Robert Hugh Jones
Publikováno v: Journal of Clinical Oncology. 40:90-90
90 Background: Darolutamide, a structurally distinct and highly potent androgen receptor inhibitor, had a consistently favorable safety and tolerability profile in patients with nonmetastatic castration-resistant prostate cancer in ARAMIS, and discon
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d9516a40be0b612ac2ae915de0285c06
https://doi.org/10.1200/jco.2022.40.6_suppl.090
Zobrazit plný text záznamu
6
Flow cytometric analysis of tumor DNA profile related to response to treatment and survival in small-cell lung cancer
Autor: VäinäMÖ T. A. Nikkanen, Jorma J. Mattila, Vesa V. Kataja, Pasi A. Koivisto, Antti T. Ojala, Markku M. T. Virén
Publikováno v: Medical Oncology. 14:35-38
Flow cytometric (FCM) analysis of tumor DNA ploidy and S-phase fraction (SPF) has been widely used to predict prognosis and treatment response in many malignant tumors, but rarely in small-cell lung cancer (SCLC). In the present study, tumor DNA ploi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d6385eef966d7ba264288847f20b1ed
https://doi.org/10.1007/bf02990943
Zobrazit plný text záznamu
7
Akademický článek
Electronic patient-reported outcomes and machine learning in predicting immune-related adverse events of immune checkpoint inhibitor therapies.
Autor: Iivanainen, Sanna1 (AUTHOR) sanna.iivanainen@ppshp.fi, Ekstrom, Jussi2 (AUTHOR), Virtanen, Henri2 (AUTHOR), Kataja, Vesa V.2 (AUTHOR), Koivunen, Jussi P.1 (AUTHOR)
Publikováno v: BMC Medical Informatics & Decision Making. 6/30/2021, Vol. 21 Issue 1, p1-8. 8p.
Zobrazit plný text záznamu
10
Akademický článek
Does the outcome of prostate cancer patients with large prostates differ from small prostate size in permanent seed, low dose-rate brachytherapy?
Autor: Aaltomaa, Sirpa H.1 (AUTHOR) sirpa.aaltomaa@kuh.fi, Kataja, Vesa V.2,3 (AUTHOR), Räty, Atte1 (AUTHOR), Palmgren, Jan-Erik2 (AUTHOR), Lahtinen, Tapani2 (AUTHOR)
Publikováno v: Scandinavian Journal of Urology & Nephrology. Nov2011, Vol. 45 Issue 5, p339-345. 7p. 2 Charts, 3 Graphs.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje